BioLizard has been listed as a Trends Gazelle
As a fast-growing company, BioLizard has been recognised as one of the companies to watch in 2025! This recognition is part of a joint initiative by Trends, Change the Game, and Kanaal Z, which closely monitors companies achieving the greatest growth based on value...
Transforming veterinary research using data science, one paw at a time
Data science is vastly changing the way we do research. Veterinary research is, however, still lagging behind its human counterpart. Why is this the case and can we learn from human health data to close this gap? Published by: BioVox on November 27, 2024 – link...
Biomarker discovery 2.0: Using new technologies to access novel insights into human health and disease
Due to the size and dimensionality of the datasets required, data science is an essential component of modern biomarker discovery and development. It’s no longer feasible to mine and process these data sets manually, which demands collaboration between R&D...
Beyond diagnostics: How biomarkers can be used to de-risk drug development
Biomarker discovery is important not only in the pursuit of better diagnostics but also for de-risking drug development. By leveraging validated biomarkers, you can prioritize drug candidates with higher likelihoods of therapeutic success, thereby reducing the risk of...